Research Programs
Academic Activity
Prof. Elena Tolstov was a principal investigator in multiple national and international studies. There are our most recent last research projects.
EEMSR21 Concept Investigation
USA-Swedish collaboration. Karolinska Institute
MMRF NIH. MN Council of Mental Health
DYSPORT™ for Injection AbobotulinumtoxinA Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR–CD).
Prospective Observational Trial Evaluating Dysport for Cervical Dystonia or Blepharospasm in the United States.
The objective of this Study is to obtain comprehensive United States (U.S.) post-marketing patient response and health economics data from adult patients with idiopathic CD who are treated with Dysport.
Prospective Observational Trial Evaluating Xeomin (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States.
The objective is to collect and evaluate observational data about the “real world” use of Xeomin to determine injection patterns and use of guidance techniques as well as to evaluate the effect of Xeomin on work productivity and quality of life. There are will be up to 807 subjects with cervical dystonia selected in about 120 U.S. treatment centers. The study shall answer the question if there are potential predictors of outcomes and treatment decisions.
USA-Swedish collaboration. Karolinska Institute
MMRF NIH. MN Council of Mental Health
DYSPORT™ for Injection AbobotulinumtoxinA Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR–CD).
Prospective Observational Trial Evaluating Dysport for Cervical Dystonia or Blepharospasm in the United States.
The objective of this Study is to obtain comprehensive United States (U.S.) post-marketing patient response and health economics data from adult patients with idiopathic CD who are treated with Dysport.
Prospective Observational Trial Evaluating Xeomin (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States.
The objective is to collect and evaluate observational data about the “real world” use of Xeomin to determine injection patterns and use of guidance techniques as well as to evaluate the effect of Xeomin on work productivity and quality of life. There are will be up to 807 subjects with cervical dystonia selected in about 120 U.S. treatment centers. The study shall answer the question if there are potential predictors of outcomes and treatment decisions.
Dr. Kurt Allenberg
(co-investigator)
Request for advice
Leave your contact details and you will be contacted
By clicking on the button, you agree to the terms of personal data
